Common use of Disclosure of ADSs Sold Clause in Contracts

Disclosure of ADSs Sold. The Company will disclose in its Annual Reports on Form 20-F and on Form 6-K when disclosing interim financial reports, as applicable, the number of ADSs sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of ADSs pursuant to this Agreement during the relevant period; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Report of Foreign Private Issuer on Form 6-K or a further Prospectus Supplement.

Appears in 5 contracts

Samples: At the Market Offering Agreement (BIT Mining LTD), At the Market Offering Agreement (Steakholder Foods Ltd.), At the Market Offering Agreement (Immuron LTD)

AutoNDA by SimpleDocs

Disclosure of ADSs Sold. The Company will disclose in its Annual Reports on Form 20-F and in its Reports on Form 6-K when disclosing interim financial reportsstatements or results, as applicable, the number of ADSs sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of ADSs pursuant to this Agreement during the relevant period; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Report of Foreign Private Issuer on Form 6-K or a further Prospectus Supplement.

Appears in 2 contracts

Samples: At the Market Offering Agreement (BioLineRx Ltd.), At the Market Offering Agreement (BioLineRx Ltd.)

Disclosure of ADSs Sold. The Company will disclose in its Annual Reports on Form 2010-F K and Quarterly Reports on Form 610-K when disclosing interim financial reportsQ, as applicable, the number of ADSs sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of ADSs pursuant to this Agreement during the relevant periodquarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report of Foreign Private Issuer on Form 68-K or a further Prospectus Supplement.

Appears in 2 contracts

Samples: At the Market Offering Agreement (Bionomics Limited/Fi), At the Market Offering Agreement (Renalytix PLC)

Disclosure of ADSs Sold. The Company will disclose in its Annual Reports on Form 20-F and on Form 6-K when disclosing interim financial reports, as applicable, the number of ADSs sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of ADSs pursuant to this Agreement during the relevant period; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report of Foreign Private Issuer on Form 6-K or a further Prospectus Supplement.

Appears in 2 contracts

Samples: At the Market Offering Agreement (Stealth BioTherapeutics Corp), At the Market Offering Agreement (ReneSola LTD)

Disclosure of ADSs Sold. The Company will disclose in its Annual Reports on Form 20-F and on Form 6-K when disclosing interim financial reports, as applicable, the number of ADSs sold through the Manager Managers under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of ADSs pursuant to this Agreement during the relevant period; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Current Report of Foreign Private Issuer on Form 6-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: At the Market Offering Agreement (ReneSola LTD)

AutoNDA by SimpleDocs

Disclosure of ADSs Sold. The Company will disclose in its Annual Reports on Form 20-F and on Form 6-K when disclosing interim quarterly financial reports, as applicable, the number of ADSs sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of ADSs pursuant to this Agreement during the relevant period; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Report of Foreign Private Issuer on Form 6-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: At the Market Offering Agreement (Canaan Inc.)

Disclosure of ADSs Sold. The Company will disclose in its Annual Reports on Form 20-F and report on Form 6-K when disclosing interim containing financial reportsinformation for the first, second or third fiscal quarters, as applicable, the number of ADSs sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of ADSs pursuant to this Agreement during the relevant periodquarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Report of Foreign Private Issuer on Form 6-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: At the Market Offering Agreement (Trinity Biotech PLC)

Disclosure of ADSs Sold. The Company will disclose in its Annual Reports on Form 20-F and on Form 6-K when disclosing interim financial reports, as applicable, the number of ADSs sold through the Manager under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales of ADSs pursuant to this Agreement during the relevant periodquarter; and, if required by any subsequent change in Commission policy or request, more frequently by means of a Report of Foreign Private Issuer on Form 6-K or a further Prospectus Supplement.

Appears in 1 contract

Samples: At the Market Offering Agreement (Can-Fite BioPharma Ltd.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!